1517 Fund
VC Fund
San Francisco, United States
1517 Fund is a VC fund in San Francisco focused on Software and Artificial Intelligence. 1517 supports teams with pre-seed and seed funding for technology startups. Their focus is on makers, hackers, and scientists interested in working outside tracked institutions because we believe that the path geared towards higher education is not for all. They motivate people to work on what they’re passionate about, to learn by doing, and tocreate new technologies.
- Total investments:
- 135
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries 1517 Fund invests in
Stages 1517 Fund invests in
Countries 1517 Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $750k–$7M
- Pre-Seed
- $240k–$3M
- Series A
- $7.6M–$41M
Investment Focus
Industry
- Software 21 (16%)
- Artificial Intelligence 12 (9%)
- Health Care 11 (8%)
- Information Technology 10 (7%)
- Biotechnology 8 (6%)
Stage
- Seed 58 (43%)
- Pre-Seed 34 (25%)
- Series A 11 (8%)
- Funding Round 7 (5%)
- Angel 4 (3%)
Country
- United States 75 (56%)
- Canada 5 (4%)
- India 1 (1%)
- Mexico 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Nick Arnett
Principal
|
Principal | Total investments: 1 | Find email | |
|
Danielle Strachman
Founder & General Partner
|
Founder & General Partner | Total investments: 14 | Find email | |
|
Michael Gibson
Founder and General Partner
|
Founder and General Partner | Total investments: 1 | Find email | |
|
Shayanne Wright
Scholar in Residence
|
Scholar in Residence | Total investments: 0 | Find email | |
|
Zachary Slayback
Principal
|
Principal | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Reprogram Biosciences is a biotechnology company that develops cancer treatment with cell reprogramming technology. | $5M / Seed / May 26, 2026 | |
|
|
corner is a social networking platform | $3.8M / Seed / Sep 18, 2025 | |
|
|
Building resilient in-space supply lines. | $12M / Seed / Aug 13, 2025 | |
|
|
AI to automate microchip design | $8M / Seed / Aug 07, 2025 | |
|
|
LLM Inference Hardware | $51.6M / Series A / Jul 28, 2025 | |
|
|
Rainmaker employs cutting-edge technology to generate rain, replenish water sources, and address drought challenges in a sustainable and effective manner. | $25M / Series A / May 05, 2025 | |
|
|
Mining technology company developing next-generation exploration drilling hardware and software. | $3.4M / Pre-Seed / Apr 23, 2025 | |
|
|
Lambda provides GPU-powered hardware, cloud, and software solutions tailored for AI model development, training, fine-tuning, inference, and deployment. Its offerings include on-demand GPU cloud instances and multi-node clusters, desktop and server workstations equipped with NVIDIA GPUs, a curated software stack for seamless integration of MLtools, and consulting services that help build scalable ML infrastructure and workflows. | $480M / Series D / Feb 19, 2025 | |
|
|
MIIST Therapeutics is a pulmonary drug delivery system and digital platform that enhances the science of inhaled drugs. In order to reduce the excessive quantity of death and sickness brought on by tobacco use, MIIST is actively developing technology that will be used as a smoking cessation therapy. | $7M / Seed / Feb 05, 2025 | |
|
|
They have built a simple system to give first responders instant situational awareness. Seconds after a 911 call comes in, their software automatically dispatches a drone to the scene of the emergency, and streams a live video feed back to our app. Their software handles everything else in the background: security, safety, weather, video, routeplanning, and more. | $5.2M / Seed / Oct 18, 2024 | |
| See all 135 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does 1517 Fund invest in?
1517 Fund invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 135 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is 1517 Fund's check size?
1517 Fund typically joins rounds of $750k–$7M at Seed, $240k–$3M at Pre-Seed and $7.6M–$41M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds 1517 Fund participates in.
How do I contact 1517 Fund?
Public channels for 1517 Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at 1517 Fund?
The team at 1517 Fund includes Nick Arnett (Principal), Danielle Strachman (Founder & General Partner) and Michael Gibson (Founder and General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!